O'SHAUGHNESSY ASSET MANAGEMENT, LLC

Position in ZYME — Zymeworks Inc.

CIK 1423442 Stamford, CT

Position in ZYME

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,033,418

+$103,708 QoQ

Shares Held

39,534

+6.5% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#88

of 202 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

O'SHAUGHNESSY ASSET MANAGEMENT, LLC holds $102,774,741 across 45 Biotechnology names. ZYME ranks #19 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	42,063	$20,893,953
2	AUPH	Aurinia Pharmaceuticals Inc.	567,492	$9,630,339
3	PBYI	Puma Biotechnology, Inc.	1,123,783	$9,113,880
4	EXEL	Exelixis, Inc.	124,709	$6,785,416
5	JAZZ	Jazz Pharmaceuticals plc	25,864	$6,232,448
6	ARGX	Argenx SE	6,450	$5,984,116
7	REGN	Regeneron Pharmaceuticals, Inc.	9,404	$5,863,770
8	RIGL	Rigel Pharmaceuticals Inc	131,177	$5,131,644

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,033,418	39,534	+6.5%	Shares	Sole	2026-08-13
2026-03-31	$929,710	37,129	-13.8%	Shares	Sole	2026-05-13
2025-12-31	$1,133,559	43,052	+3.1%	Shares	Sole	2026-02-11
2025-09-30	$713,397	41,768	+1.3%	Shares	Sole	2025-11-13
2025-06-30	$517,361	41,224	-57.2%	Shares	Sole	2025-08-12
2025-03-31	$1,147,278	96,329	-27.3%	Shares	Sole	2025-05-13
2024-12-31	$1,940,927	132,577	-8.5%	Shares	Sole	2025-02-12
2024-09-30	$1,817,842	144,848	+8.7%	Shares	Sole	2024-11-12
2024-06-30	$1,133,914	133,245	-47.8%	Shares	Sole	2024-08-14
2024-03-31	$2,687,828	255,497	+51.5%	Shares	Sole	2024-05-13
2023-12-31	$1,752,793	168,700	+35.4%	Shares	Sole	2024-02-09
2023-09-30	$789,634	124,548	+8.4%	Shares	Sole	2023-11-13
2023-06-30	$992,450	114,867	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.